Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values

Acta Pharmaceutica

Volumn 59, Issue 2, 2009, Pages 187-197

  Javadzadeh, Yousef ^a   Mohammadi, Ameneh ^a   Khoei, Nazaninossadat ^a   Nokhodchi, Ali ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

Carbamazepine; Crystalization; pH; Polymorphism

Indexed keywords

CARBAMAZEPINE;

AQUEOUS SOLUTION; ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STRUCTURE; HARDNESS; PARTICLE SIZE; PH MEASUREMENT; SCANNING ELECTRON MICROSCOPY; TABLET FORMULATION; TEMPERATURE SENSITIVITY; THERMODYNAMICS; X RAY POWDER DIFFRACTION;

EID: 67651158896     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-009-0015-x     Document Type: Article

References (14)

1. A. A. Noyes and W. R. Whitney, The rate of solution of solid substances in their own solutions, J. Am. Chem. Soc. 19 (1987) 930-934.
2. A. Nokhodchi, N. Bolourtchian and R. Dinarvand, Dissolution and mechanical behaviors of re-crystallized carbamazepine from alcohol solution in the presence of additives, J. Cryst. Growth 274 (2005) 573-584; DOI:10.1016/j.jcrysgro.2004.10.158.
3. Y. Kobayashi, Sh. Ito, Sh. Itai and K. Yamamoto, Physicochemical properties and bioavailability of carbamazepine polymorphs and dehydrate, Int. J. Pharm. 193 (2000) 137-146; DOI: 10.1016/ S0378-5173(99)00315-4.
4. A. L. Grzesiak, M. Lang, K. Kim and A. J. Matzger, Comparison of the four anhydrous poly-morphs of carbamazepine and the crystal structure of form I, J. Pharm. Sci. 92 (2003) 2260-2271; DOI: 10.1002/jps.10455.
5. P. Costa, An alternative method to the evaluation of similarity factor in dissolution testing, Int. J. Pharm. 220 (2001) 77-83; DOI: 10.1016/S0378-5173(01)00651-2.
6. M. M. J. Lowes, M. R. Caira, A. P. Lotter and J. G. Van der Watt, Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine, J. Pharm. Sci. 76 (1987) 744-752; DOI: 10.1002/jps.2600760914.
7. H. Kala, U. Haack, P. Pollandt and G. Brezesinski, Zur Polymorphie des Carbamazepine, Acta Pharm. Technol. 32 (1986) 72-77.
8. F. U. Krahn and J. B. Mielck, Relation between several polymorphic forms and the dehydrate of carbamazepine, Pharm. Acta Helv. 62 (1987) 247-254.
9. R. J. Davey, Solvent Effects in Crystallization Processes, in Current Topics in Materials Science (Ed. R. J. Davey), North-Holland Publishing Co., New York 1982, p. 8.
10. V. L. Himes, A. D. Mighell and W. H. De Camp, Structure of carbamazepine 5H-dibenz[b,f]aze-pine-5-carboxamide, Acta Crystallogr. B 37 (1981) 2242-2245.
11. rd ed., Lea & Febiger, Philadelphia 1986, pp. 316-317.
12. nd ed., Informa Health Care, New York 2004, pp. 73-74.
13. G. Alderborn, Particle Dimensions, in Pharmaceutical Powder Compaction Technology (Eds. G. Alder-born and C. Nystrom), Marcel Dekker, New York 1996, pp. 245-282.
14. G. Alderborn and C. Nystrom, Studies on direct compression of tablets. IV. The effect of particle size on the mechanical strength of tablets, Acta Pharm. Suec. 19 (1982) 381-390.